FROM THE ARTICLE

“Anecdotally, I’ve never had anybody experience any adverse effects from mifepristone or any untoward side effects that we weren’t expecting or unexplained complications from taking mifepristone.”
PRH Fellow Dr. Bhaskari Burra

Burra, a maternal fetal medicine physician in Asheville and fellow with Physicians for Reproductive Health, recently joined an amicus brief urging the U.S. Supreme Court to block a Fifth Circuit ruling that would sharply restrict remote access to mifepristone, the medication commonly used in abortion and miscarriage management.

Drawing on firsthand experiences from OB-GYNs, maternal-fetal medicine specialists, and family medicine physicians across the country, the brief emphasizes that telehealth evaluations are medically sound and that doctors are fully capable of screening patients remotely for rare complications, such as ectopic pregnancy.

The post A Doctor’s Warning From the Front Lines of Reproductive Care appeared first on Physicians for Reproductive Health.